HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 244 filers reported holding HAEMONETICS CORP in Q2 2022. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $40,221 | +5.2% | 449 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $38,228 | +2.9% | 449 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $37,155 | +51.4% | 449 | +43.9% | 0.00% | 0.0% |
Q4 2022 | $24,539 | +6.7% | 312 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $23,000 | +35.3% | 312 | +17.3% | 0.00% | 0.0% |
Q2 2022 | $17,000 | +183.3% | 266 | +186.0% | 0.00% | – |
Q1 2022 | $6,000 | +100.0% | 93 | +52.5% | 0.00% | – |
Q4 2021 | $3,000 | -85.7% | 61 | -79.3% | 0.00% | -100.0% |
Q3 2021 | $21,000 | +320.0% | 294 | +286.8% | 0.00% | – |
Q2 2021 | $5,000 | +150.0% | 76 | +347.1% | 0.00% | – |
Q1 2021 | $2,000 | -33.3% | 17 | -34.6% | 0.00% | – |
Q4 2020 | $3,000 | +200.0% | 26 | +116.7% | 0.00% | – |
Q3 2020 | $1,000 | -50.0% | 12 | -36.8% | 0.00% | – |
Q2 2020 | $2,000 | -93.5% | 19 | -93.9% | 0.00% | -100.0% |
Q1 2020 | $31,000 | -13.9% | 312 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $36,000 | -7.7% | 312 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $39,000 | +2.6% | 312 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $38,000 | +40.7% | 312 | 0.0% | 0.00% | +50.0% |
Q1 2019 | $27,000 | -15.6% | 312 | -2.2% | 0.00% | -33.3% |
Q4 2018 | $32,000 | -13.5% | 319 | 0.0% | 0.00% | -25.0% |
Q3 2018 | $37,000 | +27.6% | 319 | 0.0% | 0.00% | +33.3% |
Q2 2018 | $29,000 | +26.1% | 319 | +2.2% | 0.00% | 0.0% |
Q1 2018 | $23,000 | – | 312 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Millrace Asset Group, Inc. | 19,264 | $1,726 | 2.13% |
Parkman Healthcare Partners LLC | 88,962 | $7,969,216 | 1.46% |
HEARTLAND ADVISORS INC | 256,414 | $24,435,274 | 1.37% |
Riverwater Partners LLC | 15,553 | $1,393,238 | 1.27% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 111,100 | $9,952,338 | 1.15% |
Lisanti Capital Growth, LLC | 78,425 | $7,025,312 | 1.11% |
Aristotle Capital Boston, LLC | 311,666 | $27,919,054 | 0.90% |
ROYCE & ASSOCIATES LP | 947,550 | $84,881,529 | 0.86% |
CHASE INVESTMENT COUNSEL CORP | 18,770 | $1,681 | 0.84% |
Virtus Investment Advisers, Inc. | 13,662 | $1,223,842 | 0.83% |